AGC Biologics A/S

AGC Biologics A/S (CVR number: 25950941) is a company from GLADSAXE. The company reported a net sales of 2092.6 mDKK in 2023, demonstrating a decline of -16.9 % compared to the previous year. The operating profit percentage was at 16.8 % (EBIT: 352.2 mDKK), while net earnings were 243.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 10.3 %, which can be considered good but Return on Equity (ROE) was 50.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 49.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. AGC Biologics A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.